ANN-MARIE SPINELLA: Open Payments
NPI 1619699618 · HAUPPAUGE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 15 payments from 7 companies in 2025. Trend: 2023 $67 · 2024 $44 · 2025 $495
Food & beverage: $395Education: $100
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $209 |
| E.R. Squibb & Sons, L.L.C. | 3 | $83 |
| Neurocrine BioSciences, Inc. | 2 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| Vanda Pharmaceuticals Inc. | 1 | $38 |
| Corium, LLC | 1 | $22 |
| Alkermes, Inc. | 1 | $21 |
Products named: AUSTEDO XR, COBENFY, INGREZZA, CAPLYTA, HETLIOZ, Azstarys, LYBALVI.
Industry payments across NY — which companies pay providers there.
